| 08/18/2026 3:20 PM | Eli Lilly and Company (59478) Issuer Jonsson Patrik (1786054) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 3:21 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/17/2026 4:06 PM | Eli Lilly and Company (59478) Subject Jonsson Patrik (1786054) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/11/2026 3:31 PM | Eli Lilly and Company (59478) Issuer Zakrowski Donald A (1561539) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/10/2026 3:31 PM | Eli Lilly and Company (59478) Subject Zakrowski Donald A (1561539) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/10/2026 3:19 PM | Eli Lilly and Company (59478) Issuer Hakim Anat (1685556) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 9:30 AM | Eli Lilly and Company (59478) Subject Hakim Anat (1685556) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/05/2026 1:40 PM | Eli Lilly and Company (59478) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2026 6:05 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/03/2026 3:42 PM | Eli Lilly and Company (59478) Issuer Seymour Melissa (2032089) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/30/2026 3:39 PM | Eli Lilly and Company (59478) Filed by Scribe Therapeutics, Inc. (1853921) Subject | Form SCHEDULE 13D | |
Get the Latest News and Ratings for LLY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eli Lilly and Company and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/21/2026 3:37 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 3:39 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 3:39 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 3:40 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 2:02 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/26/2026 12:40 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/23/2026 2:26 PM | Eli Lilly and Company (59478) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/16/2026 3:13 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 3:14 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 10:03 AM | Eli Lilly and Company (59478) Subject Yuffa Ilya (1826001) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/02/2026 8:16 AM | Eli Lilly and Company (59478) Subject NEW YORK STOCK EXCHANGE LLC (876661) Filed by | Form 25-NSE | |
| 05/28/2026 2:02 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/22/2026 1:05 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/20/2026 3:30 PM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 3:22 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/19/2026 3:16 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:17 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:18 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/19/2026 3:19 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/08/2026 5:05 AM | Eli Lilly and Company (59478) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 05/07/2026 3:41 PM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 4:25 PM | Eli Lilly and Company (59478) Subject | Form FWP | |
| 05/06/2026 3:35 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/06/2026 7:04 AM | Eli Lilly and Company (59478) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 04/30/2026 10:25 AM | Eli Lilly and Company (59478) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/30/2026 6:03 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 12:18 PM | Eli Lilly and Company (59478) Subject Friends Fiduciary Corp (1696940) Filed by | Form PX14A6G | |
| 04/21/2026 3:14 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:16 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 3:18 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad) Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.
|
| 04/21/2026 3:20 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 2:25 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Filed by | Form SCHEDULE 13G/A | |
| 03/31/2026 7:18 AM | Centessa Pharmaceuticals plc (1847903) Subject Eli Lilly and Company (59478) Filed by | Form DFAN14A | |
| 03/26/2026 5:02 PM | Eli Lilly and Company (59478) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/20/2026 3:23 PM | Eli Lilly and Company (59478) Filer | Form DEFA14A | |
| 03/17/2026 3:29 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 3:30 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:35 PM | Eli Lilly and Company (59478) Filer | Form PRE 14A | |
| 02/19/2026 3:18 PM | Dozier Eric (1955972) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 3:22 PM | Eli Lilly and Company (59478) Issuer Rau Diogo (1860253) Reporting | Form 4/A | |
| 02/12/2026 12:58 PM | Eli Lilly and Company (59478) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/11/2026 3:14 PM | Custer Kenneth L. (2071542) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:16 PM | Dozier Eric (1955972) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:17 PM | Eli Lilly and Company (59478) Issuer Hakim Anat (1685556) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:17 PM | Eli Lilly and Company (59478) Issuer Hernandez Edgardo (1861052) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:19 PM | Eli Lilly and Company (59478) Issuer Jonsson Patrik (1786054) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:20 PM | Eli Lilly and Company (59478) Issuer Montarce Lucas (1752447) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 3:22 PM | Eli Lilly and Company (59478) Issuer Rau Diogo (1860253) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 6:05 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/23/2026 8:27 AM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Filed by | Form SCHEDULE 13G/A | |
| 01/21/2026 3:25 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:27 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 5:01 AM | Aktis Oncology, Inc. (2035832) Issuer Eli Lilly and Company (59478) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/15/2026 5:02 AM | Aktis Oncology, Inc. (2035832) Subject Eli Lilly and Company (59478) Filed by | Form SCHEDULE 13D | |
| 12/23/2025 11:52 AM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:41 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:42 PM | Eli Lilly and Company (59478) Issuer Fyrwald J Erik (1343564) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:43 PM | Eli Lilly and Company (59478) Issuer Hedley Mary Lynne (1340823) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:45 PM | Eli Lilly and Company (59478) Issuer LUCIANO JUAN R (1455792) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:46 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 7:46 AM | Adverum Biotechnologies, Inc. (1501756) Subject Eli Lilly and Company (59478) Filed by | Form SC TO-T/A | |
| 12/08/2025 3:10 PM | Bertozzi Carolyn R (1698766) Reporting Eli Lilly and Company (59478) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 11/24/2025 2:01 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/21/2025 3:19 PM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/20/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 2:05 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 3:39 PM | Eli Lilly and Company (59478) Issuer JOHNSON KIMBERLY H (1658089) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:25 PM | Eli Lilly and Company (59478) Issuer Moeller Jon R (1450613) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:26 PM | Eli Lilly and Company (59478) Issuer Sulzberger Gabrielle (1262388) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:17 PM | Eli Lilly and Company (59478) Issuer Hedley Mary Lynne (1340823) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:19 PM | Eli Lilly and Company (59478) Issuer JACKSON JAMERE (1601813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:21 PM | Eli Lilly and Company (59478) Issuer Kaelin William G Jr (1551715) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:12 PM | Alvarez Ralph (1310215) Reporting Eli Lilly and Company (59478) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 2:02 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/12/2025 2:15 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2025 5:00 PM | Eli Lilly and Company (59478) Issuer Skovronsky Daniel (1741474) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 5:01 PM | Eli Lilly and Company (59478) Issuer Ricks David A (1538604) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself |
| 11/10/2025 2:11 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/04/2025 3:00 PM | Eli Lilly and Company (59478) Issuer LILLY ENDOWMENT INC (316011) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2025 2:05 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/03/2025 2:06 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/30/2025 4:34 PM | Eli Lilly and Company (59478) Subject LILLY ENDOWMENT INC (316011) Filed by | Form SCHEDULE 13G/A | |
| 10/30/2025 1:54 PM | Eli Lilly and Company (59478) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 10/30/2025 10:15 AM | Eli Lilly and Company (59478) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/30/2025 6:03 AM | Eli Lilly and Company (59478) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/24/2025 3:30 PM | Adverum Biotechnologies, Inc. (1501756) Subject Eli Lilly and Company (59478) Filed by | Form SC TO-C | |